Plasma-generated hydroxyl radicals ( ^· OH) and oxygen atoms (O) produced by the COST reference plasma jet, a micro-scaled atmospheric pressure plasma jet, were investigated using a variety of experimental techniques. Several gas admixtures were studied to distinguish the contributions of the two reactive oxygen species. Large discrepancies between inferred aqueous ^· OH densities were noted when using a 2-hydroxyterephthalic acid (HTA) fluorescence assay and electron paramagnetic resonance (EPR) measurements with the spin trap 5,5-dimethyl-1-pyrroline N -oxide—especially when oxygen was present in the feed gas. A series of follow-up experiments including optical emission spectroscopy, H ₂ O ₂ quantification, and EPR measurements of atomic oxygen using the spin trap 2,2,6,6-tetramethylpiperidine, revealed that the inconsistencies between the measured aqueous ^· OH were likely due to the propensity of atomic oxygen to hydroxylate TA in a manner indistinguishable from ^· OH. This renders the HTA assay non-selective when both ^· OH radicals and atomic oxygen are present, which we report for all three gas admixtures in our experiments. Additionally, considerable degradation of both HTA and the spin adducts measured using EPR spectroscopy was apparent, meaning actual radical densities in the plasma-treated liquid may be considerably higher than implied. Degradation rates compared favorably to previously measured gas phase densities of atomic oxygen in the predecessor of the COST jet and reported degradation of other chemical probes. These results show the prolific role of atomic oxygen in plasma-induced liquid chemistry and caution against diagnostic techniques that are unable to account for it.

Purpose: [131I]meta-iodobenzylguanidine ([131I]MIBG) is a targeted radiotherapeutic administered systemically to deliver beta particle radiation in neuroblastoma. However, relapses in the bone marrow are common. [211At]meta-astatobenzylguanidine ([211At] MABG) is an alpha particle emitter with higher biological effectiveness and short path length which effectively sterilizes microscopic residual disease. Here we investigated the safety and antitumor activity [211At]MABG in preclinical models of neuroblastoma. Experimental Design: We defined the maximum tolerated dose (MTD), biodistribution, and toxicity of [211At]MABG in immunodeficient mice in comparison with [131I]MIBG. We compared the antitumor efficacy of [211At]MABG with [131I]MIBG in three murine xenograft models. Finally, we explored the efficacy of [211At]MABG after tail vein xenografting designed to model disseminated neuroblastoma. Results: The MTD of [211At]MABG was 66.7 MBq/kg (1.8 mCi/kg) in CB17SC scid−/− mice and 51.8 MBq/kg (1.4 mCi/kg) in NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice. Biodistribution of [211At]MABG was similar to [131I]MIBG. Long-term toxicity studies on mice administered with doses up to 41.5 MBq/kg (1.12 mCi/kg) showed the radiotherapeutic to be well tolerated. Both 66.7 MBq/kg (1.8 mCi/kg) single dose and fractionated dosing 16.6 MBq/kg/fraction (0.45 mCi/kg) × 4 over 11 days induced marked tumor regression in two of the three models studied. Survival was significantly prolonged for mice treated with 12.9 MBq/kg/fraction (0.35 mCi/kg) × 4 doses over 11 days [211At]MABG in the disseminated disease (IMR-05NET/GFP/LUC) model (P = 0.003) suggesting eradication of microscopic disease. Conclusions: [211At]MABG has significant survival advantage in disseminated models of neuroblastoma. An alpha particle emitting radiopharmaceutical may be effective against microscopic disseminated disease, warranting clinical development.

This study investigated the use of glutathione as a marker to establish a correlation between plasma parameters and the resultant liquid chemistry from two distinct sources to predefined biological outcomes. Two different plasma sources were operated at parameters that resulted in similar biological responses: cell viability, mitochondrial activity, and the cell surface display of calreticulin. Specific glutathione modifications appeared to be associated with biological responses elicited by plasma. These modifications were more pronounced with increased treatment time for the European Cooperation in Science and Technology Reference Microplasma Jet (COST-Jet) and increased frequency for the dielectric barrier discharge and were correlated with more potent biological responses. No correlations were found when cells or glutathione were exposed to exogenously added long-lived species alone. This implied that short-lived species and other plasma components were required for the induction of cellular responses, as well as glutathione modifications. These results showed that comparisons of medical plasma sources could not rely on measurements of long-lived chemical species; rather, modifications of biomolecules (such as glutathione) might be better predictors of cellular responses to plasma exposure.

Applied cold atmospheric plasma allows for the controlled delivery of reactive oxygen and nitrogen species tailored for specific applications. Through the manipulation of the plasma parameters, feed gases, and careful consideration of the environment surrounding the treatment target, selective chemistries that preferentially influence the target can be produced and delivered. To demonstrate this, the COST reference microscale atmospheric pressure plasma jet is used to study the generation and transport of O and ⋅ OH from the gas phase through the liquid to the biological model target cysteine. Relative and absolute species densities of ⋅ OH and O are measured in the gas phase through laser induced fluorescence (LIF) and two-photon absorption LIF respectively. The transport of these species is followed into the liquid phase by hydrogen peroxide quantification and visualized by a fluorescence assay. Modifications to the model biological sample cysteine exposed to ⋅ OH and H₂O₂ dominated chemistry (He/H₂O (0.25%)) and O dominated chemistry (He/O₂ (0.6%)) is measured by FTIR spectroscopy. The origin of these species that modify cysteine is considered through the use of heavy water (H 2 18 O) and mass spectrometry. It is found that the reaction pathways differ significantly for He/O₂ and He/H₂O. Hydrogen peroxide is formed mainly in the liquid phase in the presence of a substrate for He/O₂ whereas for He/H₂O it forms in the gas phase. The liquid chemistry resulting from the He/O₂ admixture mainly targets the sulfur moiety of cysteine for oxidation up to irreversible oxidation states, while He/H₂O treatment leads preferentially to reversible oxidation products. The more O or OH/H₂O₂ dominated chemistry produced by the two gas admixtures studied offers the possibility to select species for target modification.